Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Akebia Therapeutics, Inc.AKBA · Entity 6105 | SVP, Chief Medical Officer | February 02, 2026 | February 04, 2026 |
| Protara Therapeutics, Inc.PRTO · Entity 6203 | SVP and Chief Medical Officer | March 15, 2019 | March 18, 2019 |
| SCYNEXIS INCSCYX · Entity 7194 | Director | September 18, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Akebia Therapeutics, Inc.
Report date February 02, 2026 · Filed February 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 948,432 |
Ending reported balance
After 2026-02-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-02 · Sale · Disposed 21,582 · Balance 994,508 F1: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F2: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. Row 2 · 2026-02-02 · Sale · Disposed 25,375 · Balance 969,133 F1: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F3: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Row 3 · 2026-02-02 · Sale · Disposed 20,701 · Balance 948,432 F1: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F4: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.
F2: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023.
F3: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.
F4: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.
Protara Therapeutics, Inc.
Report date March 15, 2019 · Filed March 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 116,584 |
Reported balance
After 2019-03-15 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-03-15 · Gift · Disposed 7,334 · Balance 116,584 F1: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 109,251 |
Reported balance
After 2019-03-15 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-03-15 · Gift · Disposed 7,333 · Balance 109,251 F2: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 101,917 |
Reported balance
After 2019-03-15 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2019-03-15 · Gift · Disposed 7,333 · Balance 101,917 F3: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 18,999 |
Reported balance
After 2019-03-15 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2019-03-15 · Gift · Acquired 7,333 · Balance 18,999 F2: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 26,332 |
Reported balance
After 2019-03-15 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2019-03-15 · Gift · Acquired 7,333 · Balance 26,332 F3: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F2: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F3: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
SCYNEXIS INC
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,750 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 5,750 · Balance 5,750 F1: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each RSU upon vesting. 1/3rd of the RSUs will vest annually on the anniversary of the date of grant, with the first 1/3rd vesting on September 18, 2027, provided that the Reporting Person is providing continuous services on the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.46 · Expires 2036-09-18 | Direct | 5,750 |
Reported balance
After 2026-09-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-18 · Grant · Acquired 5,750 · Balance 5,750 F2: One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter provided that the Reporting Person is providing continuous services on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each RSU upon vesting. 1/3rd of the RSUs will vest annually on the anniversary of the date of grant, with the first 1/3rd vesting on September 18, 2027, provided that the Reporting Person is providing continuous services on the applicable vesting date.
F2: One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter provided that the Reporting Person is providing continuous services on the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 13:19 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantCommon Stock | 2,448 | $1.93 | $4,724.64 |
DisclosureSEC source: 0001171843-19-000063 · ownership.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,917 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 12:19 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantCommon Stock | 10,000 | $1.62 | $16,150.00 |
DisclosureSEC source: 0001171843-18-004988 · formfour.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,469 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:16 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000440 · formfour.xml · derivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, $0.001 par value · 200,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 13:15 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantCommon Stock | 3,934 | $1.30 | $5,098.46 |
DisclosureSEC source: 0001171843-18-000081 · form4burke.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,469 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 6 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,666 F4 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 5 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,333 F3 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,535 F4 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,868 F3 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,201 F2 · kind: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | PurchaseCommon Stock | 12,000 | $1.88 | $22,560.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,535 F1 · price: The purchase price of $1.88 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.875 to $1.9. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:10 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantCommon Stock | 10,000 | $1.30 | $12,960.00 |
DisclosureSEC source: 0001171843-17-003951 · formfour.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,535 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:00 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | Exercise / conversionStock Option (Right to Buy) · Derivative | 57,934 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001171843-17-001479 · form4.xml · derivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.001 par value · 57,934 shares Expires 2021-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on October 26, 2011. All shares underlying the option have vested. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:00 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,287 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001171843-17-001479 · form4.xml · derivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.001 par value · 12,287 shares Expires 2017-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on September 10, 2007. All shares underlying the option have vested. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:00 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | Exercise / conversionCommon Stock | 57,934 | $1.27 | $73,576.18 |
DisclosureSEC source: 0001171843-17-001479 · form4.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:00 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | Exercise / conversionCommon Stock | 12,287 | $2.38 | $29,243.06 |
DisclosureSEC source: 0001171843-17-001479 · form4.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 13:00 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 53,119 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001171843-17-000451 · formfour.xml · derivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,119 Underlying: Common Stock, $0.001 par value · 53,119 shares Expires 2027-01-23 F1 · derivative.exercise_date: The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:30 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-16-013526 · f4_burke120616.xml · nonDerivative · entry 5 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,000 F3 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:30 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-16-013526 · f4_burke120616.xml · nonDerivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,500 F2 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:30 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-16-013526 · f4_burke120616.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,314 F3 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:30 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-16-013526 · f4_burke120616.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,814 F2 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:30 UTC | Protara Therapeutics, Inc. PRTO · Entity 6203 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-16-013526 · f4_burke120616.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,314 F1 · kind: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F1 · shares: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.